Skip to main content
OpenTrials

Clinical trial condition

Solid Tumors

Explore clinical trials studying Solid Tumors. Study availability and eligibility vary by location and protocol.

601 public trials 90 recruiting studies
Refine in advanced search Browse all conditions

Solid Tumors trial results

Recruiting

A Study to Test How Different Doses of BI 1703880 in Combination With Ezabenlimab Are Tolerated in People With Different Types of Advanced Cancer (Solid Tumours)

NCT05471856

Conditions
Solid Tumors
Locations
  • Valkyrie Clinical Trials Los Angeles, California, United States
  • Yale University School of Medicine New Haven, Connecticut, United States
  • John Theurer Cancer Center Hackensack, New Jersey, United States
  • National Cancer Center Hospital East Chiba, Kashiwa, Japan
View all 13 locations
View Trial Details
Recruiting

A Study to Assess the Efficacy and Safety of FORE8394 in Participants With Cancer Harboring BRAF Alterations

NCT05503797

Conditions
Adenocarcinoma, Adnexal Diseases, Biliary Tract Diseases, +52 more
Locations
  • Precision NextGen Oncology & Research Center Beverly Hills, California, United States
  • UCSF Helen Diller Family Comprehensive Cancer Center San Francisco, California, United States
  • University of California Los Angeles Rheumatology Westwood, Los Angeles, California, United States
  • Norwalk Hospital Norwalk, Connecticut, United States
View all 70 locations
View Trial Details
Recruiting

Safety and Efficacy of Ponatinib for Treatment of Pediatric Recurrent or Refractory Leukemias, Lymphomas or Solid Tumors

NCT03934372

Conditions
Accelerated Phase Chronic Myeloid Leukemia, Acute Lymphoblastic Leukemia, Acute Lymphocytic Leukemia, +31 more
Locations
  • Ghent University Hospital Ghent, Belgium
  • Hopital Robert Debre Paris, France
  • Armand Trousseau Hospital Paris, France
  • Centre Hospitalier Universitaire de Poitiers Poitiers, France
View all 23 locations
View Trial Details
Recruiting

A Study to Evaluate the Safety of INCA33890 in Participants With Advanced or Metastatic Solid Tumors

NCT05836324

Conditions
Advanced Solid Tumors, Metastatic Solid Tumors, Solid Tumors
Locations
  • The Angeles Clinic and Research Institute Los Angeles, California, United States
  • Valkyrie Clinical Trials Los Angeles, California, United States
  • Dana Farber Cancer Institute Boston, Massachusetts, United States
  • Cancer and Hematology Centers of Western Michigan-Start Midwest Grand Rapids, Michigan, United States
View all 39 locations
View Trial Details
Recruiting

Phase 1a/b Study of ZL-6201 Safety, PK, and Preliminary Efficacy in Sarcoma and Selected Tumors

NCT07374848

Conditions
Neoplasms, Neoplasms by Histologic Type, Neoplasms, Connective and Soft Tissue, +3 more
Locations
  • Zai Lab Site 02003 Los Angeles, California, United States
  • Zai Lab Site 02030 New Haven, Connecticut, United States
  • Zai Lab Site 02026 Sarasota, Florida, United States
  • Zai Lab Site 02005 St Louis, Missouri, United States
View Trial Details
Recruiting

A Study to Evaluate INCB161734 in Participants With Advanced or Metastatic Solid Tumors With KRAS G12D Mutation

NCT06179160

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +17 more
Locations
  • Mayo Clinic Hospital Phoenix, Arizona, United States
  • Stanford University Palo Alto, California, United States
  • UCLA Healthcare Hematology-Oncology Santa Monica, California, United States
  • Sarah Cannon Research Institue At Healthone Denver, Colorado, United States
View all 34 locations
View Trial Details
Recruiting

Study of AUBE00 in Patients With Solid Tumors

NCT07030959

Conditions
Solid Tumors
Locations
  • South Texas Accelerated Research Therapeutics (START) Midwest Grand Rapids, Michigan, United States
  • The University of Texas MD Anderson Cancer Center Houston, Texas, United States
  • National Cancer Center Hospital East Kashiwa, Chiba, Japan
  • National Cancer Center Hospital Chuo-ku, Tokyo, Japan
View Trial Details

Related conditions